by Advize Admin | Aug 12, 2022 | Business, Healthcare
For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits. But the hyperbole reached a new pitch in recent weeks as the Senate moved to adopt modest drug pricing negotiation measures in the...
by Erik Consorsha | Jan 14, 2022 | Healthcare
Click here for a transcript of the episode. In this episode of What the Health: Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer’s drug, to only patients participating in the approved clinical trials. The...
Recent Comments